Literature DB >> 22837489

A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing.

Irini Evnouchidou1, James Birtley, Sergey Seregin, Athanasios Papakyriakou, Efthalia Zervoudi, Martina Samiotaki, George Panayotou, Petros Giastas, Olivia Petrakis, Dimitris Georgiadis, Andrea Amalfitano, Emmanuel Saridakis, Irene M Mavridis, Efstratios Stratikos.   

Abstract

Endoplasmic reticulum aminopeptidases 1 and 2 (ERAP1 and ERAP2) cooperate to trim antigenic peptide precursors for loading onto MHC class I molecules and help regulate the adaptive immune response. Common coding single nucleotide polymorphisms in ERAP1 and ERAP2 have been linked with predisposition to human diseases ranging from viral and bacterial infections to autoimmunity and cancer. It has been hypothesized that altered Ag processing by these enzymes is a causal link to disease etiology, but the molecular mechanisms are obscure. We report in this article that the common ERAP2 single nucleotide polymorphism rs2549782 that codes for amino acid variation N392K leads to alterations in both the activity and the specificity of the enzyme. Specifically, the 392N allele excises hydrophobic N-terminal residues from epitope precursors up to 165-fold faster compared with the 392K allele, although both alleles are very similar in excising positively charged N-terminal amino acids. These effects are primarily due to changes in the catalytic turnover rate (k(cat)) and not in the affinity for the substrate. X-ray crystallographic analysis of the ERAP2 392K allele suggests that the polymorphism interferes with the stabilization of the N terminus of the peptide both directly and indirectly through interactions with key residues participating in catalysis. This specificity switch allows the 392N allele of ERAP2 to supplement ERAP1 activity for the removal of hydrophobic N-terminal residues. Our results provide mechanistic insight to the association of this ERAP2 polymorphism with disease and support the idea that polymorphic variation in Ag processing enzymes constitutes a component of immune response variability in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22837489      PMCID: PMC3530405          DOI: 10.4049/jimmunol.1200918

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Endoplasmic reticulum aminopeptidases: Biology and pathogenic potential.

Authors:  Nigil Haroon; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

2.  Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitors.

Authors:  Anastasios Makaritis; Dimitris Georgiadis; Vincent Dive; Athanasios Yiotakis
Journal:  Chemistry       Date:  2003-05-09       Impact factor: 5.236

3.  Synthesis, structure determination, and biological evaluation of destruxin E.

Authors:  Masahito Yoshida; Hisayuki Takeuchi; Yoshitaka Ishida; Yoko Yashiroda; Minoru Yoshida; Motoki Takagi; Kazuo Shin-ya; Takayuki Doi
Journal:  Org Lett       Date:  2010-09-03       Impact factor: 6.005

Review 4.  Genetics of ankylosing spondylitis.

Authors:  Matthew A Brown
Journal:  Curr Opin Rheumatol       Date:  2010-03       Impact factor: 5.006

5.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

6.  Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1.

Authors:  Yoshikuni Goto; Akira Hattori; Yasuhiro Ishii; Masafumi Tsujimoto
Journal:  FEBS Lett       Date:  2006-02-24       Impact factor: 4.124

Review 7.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

8.  Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1.

Authors:  Tina T Nguyen; Shih-Chung Chang; Irini Evnouchidou; Ian A York; Christos Zikos; Kenneth L Rock; Alfred L Goldberg; Efstratios Stratikos; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2011-04-10       Impact factor: 15.369

9.  In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules.

Authors:  Jingbo Yan; Vrajesh V Parekh; Yanice Mendez-Fernandez; Danyvid Olivares-Villagómez; Srdjan Dragovic; Timothy Hill; Derry C Roopenian; Sebastian Joyce; Luc Van Kaer
Journal:  J Exp Med       Date:  2006-02-27       Impact factor: 14.307

10.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more
  43 in total

1.  Reply to Robinson and Brown: It is the combination of ERAP1 allotypes that identifies individuals with Ankylosing Spondylitis.

Authors:  Emma Reeves; Alexandra Colebatch-Bourn; Tim Elliott; Christopher J Edwards; Edward James
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-12       Impact factor: 11.205

2.  Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.

Authors:  Pablo Guasp; Elena Lorente; Adrian Martín-Esteban; Eilon Barnea; Paolo Romania; Doriana Fruci; JonasJ W Kuiper; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-05-15       Impact factor: 5.911

3.  Crystal Structures of ERAP2 Complexed with Inhibitors Reveal Pharmacophore Requirements for Optimizing Inhibitor Potency.

Authors:  Anastasia Mpakali; Petros Giastas; Rebecca Deprez-Poulain; Athanasios Papakyriakou; Despoina Koumantou; Ronan Gealageas; Sofia Tsoukalidou; Dionisios Vourloumis; Irene M Mavridis; Efstratios Stratikos; Emmanuel Saridakis
Journal:  ACS Med Chem Lett       Date:  2017-02-21       Impact factor: 4.345

Review 4.  Genetic associations and functional characterization of M1 aminopeptidases and immune-mediated diseases.

Authors:  N Agrawal; M A Brown
Journal:  Genes Immun       Date:  2014-08-21       Impact factor: 2.676

5.  Substantial Influence of ERAP2 on the HLA-B*40:02 Peptidome: Implications for HLA-B*27-Negative Ankylosing Spondylitis.

Authors:  Elena Lorente; Jennifer Redondo-Antón; Adrian Martín-Esteban; Pablo Guasp; Eilon Barnea; Pilar Lauzurica; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-09-17       Impact factor: 5.911

Review 6.  Endoplasmic Reticulum Aminopeptidase 2, a common immunological link to adverse pregnancy outcomes and cancer clearance?

Authors:  Eun D Lee
Journal:  Placenta       Date:  2017-03-18       Impact factor: 3.481

Review 7.  The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.

Authors:  C Vitulano; V Tedeschi; F Paladini; R Sorrentino; M T Fiorillo
Journal:  Clin Exp Immunol       Date:  2017-08-30       Impact factor: 4.330

8.  Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2.

Authors:  Anastasia Mpakali; Petros Giastas; Nikolas Mathioudakis; Irene M Mavridis; Emmanuel Saridakis; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

9.  Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses.

Authors:  Charles T Spencer; Srdjan M Dragovic; Stephanie B Conant; Jennifer J Gray; Mu Zheng; Parimal Samir; Xinnan Niu; Magdalini Moutaftsi; Luc Van Kaer; Alessandro Sette; Andrew J Link; Sebastian Joyce
Journal:  Eur J Immunol       Date:  2013-03-05       Impact factor: 5.532

10.  ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.

Authors:  Philip C Robinson; Mary-Ellen Costello; Paul Leo; Linda A Bradbury; Kelly Hollis; Adrian Cortes; Seunghun Lee; Kyung Bin Joo; Seung-Cheol Shim; Michael Weisman; Michael Ward; Xiaodong Zhou; Henri-Jean Garchon; Gilles Chiocchia; Johannes Nossent; Benedicte A Lie; Øystein Førre; Jaakko Tuomilehto; Kari Laiho; Lei Jiang; Yu Liu; Xin Wu; Dirk Elewaut; Ruben Burgos-Vargas; Lianne S Gensler; Simon Stebbings; Nigil Haroon; Juan Mulero; Jose Luis Fernandez-Sueiro; Miguel A Gonzalez-Gay; Carlos Lopez-Larrea; Paul Bowness; Karl Gafney; John S Hill Gaston; Dafna D Gladman; Proton Rahman; Walter P Maksymowych; Huji Xu; Irene E van der Horst-Bruinsma; Chung-Tei Chou; Raphael Valle-Oñate; María Consuelo Romero-Sánchez; Inger Myrnes Hansen; Fernando M Pimentel-Santos; Robert D Inman; Javier Martin; Maxime Breban; David Evans; John D Reveille; Tae-Hwan Kim; B Paul Wordsworth; Matthew A Brown
Journal:  Ann Rheum Dis       Date:  2015-04-27       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.